The authors examine the relationship between market competition and the use of surgical services for cancer to test the theory that market competition promotes patient access and health care delivery.

Mexico’s plan to implement a large-scale residential distributed photovoltaic generation program would bring more economic and environmental gains than losses, the authors conclude in this study of Mexico’s electricity sector. IAEE Energy Forum: http://bit.ly/2GoTxK5

This paper proposes a new regulatory incentive mechanism to induce efficient investment in electricity transmission networks. Energy Economics: http://bit.ly/2PeCEpu

The author reviews some of the regulatory, financial and planning challenges for electricity transmission. Economics of Energy & Environmental Policy symposium: http://bit.ly/2KMRUvf.

This paper assesses the current operational conditions of the Mexican residential electricity sector and examines the potential effects that the massive adoption of distributed photovoltaic power generation (DPV) systems would have on household expenditure and welfare, subsidy reduction, pollution and water resource usage.

The authors calculate nodal prices for Mexico's power system and analyze how the allocation of financial transmission rights can be used to mitigate resulting effects on electricity distribution. The Energy Journal: http://bit.ly/2UKrw9R

Mexico should consider expanding its 2014 energy reform legislation by further designing policies that seek to promote enhanced generation output and capacity, which could expand economic growth, the authors write in this study: http://bit.ly/2DpaDai

Mexico's electricity market has engaged in a deep reform process after decades of a state-owned, vertically integrated, noncompetitive closed industry. Using different modeling strategies, the authors of this paper analyze electricity transmission planning under the new industrial and institutional structure, which is characterized by a nodal pricing system and an independent system operator (ISO).

Abstract

Alternative economic theories yield dramatically different prescriptions for optimal capital taxation in small…

Regenerative medicine and stem cell research are exciting new fields. But as the fields progress toward clinical therapies, controversies emerge. Hype surrounding stem cell research has caused an increase in their use in interventions that are not clinically proven. Furthermore, the regulatory agencies have a lot of difficulty dealing with cell therapies, which are distinctly different from drugs and medical devices they more commonly approve. To move the field forward, advocates, regulators and scientists need to come together to find new options for stem cell research oversight that protects both the patients and the research field.